VSTM

6.3307.73%
DW

Daniel W. Paterson

President, CEO & Director

Mr. Daniel W. Paterson, also known as Dan, serves as Chief Executive Officer Verastem, Inc. since August 1, 2023 and is its President of Verastem, Inc. since June 2019. He is Director of Verastem, Inc. since July 2023. Mr. Paterson served as Chief Operating Officer of Verastem, Inc. since December 12, 2014 until July 2023. Mr. Paterson served as Chief Business Officer of Verastem, Inc. from July 2013 to December 12, 2014. Mr. Paterson served as the Vice President and Head of Corporate Development and Diagnostics at Verastem, Inc. from March 2012 to July 2013. He joined Verastem, Inc. March 2012. Mr. Paterson was a consultant in 2011. From 2009 through 2010, Mr. Paterson served as the Chief Operating Officer of On-Q-ity Inc. Mr. Paterson served as the Chief Executive Officer and President of On-Q-ity Inc. (formerly, DNA Repair Company) from 2006 until 2009. Mr. Paterson’s background includes healthcare industry, with extensive experience in oncology and almost two decades managing venture-backed healthcare companies. He served as the Head of Global Strategy of Specialty Market and Patient-level Data at IMS Health. He joined IMS following the acquisition of PharMetrics where he served as a Vice President of Marketing and Corporate Development and also served as PharMetrics’ Vice President of Sales, Marketing and Business Development. He was responsible for developing strategy, product portfolio and key Partnerships, resulting in the sale to IMS Health. He served as a Vice President of Product Management and Vice President of Business Development at CareTools, an innovative healthcare information systems company, where he had primary responsibility for management of the product portfolio and Partnership strategy. Prior to CareTools he served as a Member of the founding management team of OnCare. Mr. Paterson began his career designing and managing clinical-trials programs in both industry and academic settings, including management of a nation-wide oncology clinical trials consortium Headquartered at the Dana Farber Cancer Institute. He served as a Director of On-Q-ity Inc. Mr. Paterson serves as a Member of Advisory Board of Vitality, Inc. Mr. Paterson holds a B. A. in Biology from Boston University and attended Northeastern University Graduate Pharmacology Program. Previously, he held senior level positions at Axion.

公司职务